Page 43 - merged

Friday, 20 November Index
Session #
Abstract Title

P2‐185 (AsCNP) rTMS in Fibromyalgia Patients Diagnosed by 2010 New Fibromyalgia Criteria: A Randomized
Double‐Blind Sham Control Trial
Chih‐Ming Cheng (Taiwan)

P2‐186 (WPAIC) Survey of Psychiatric Impairment for Mailiao Residences in Taiwan After the Execution of Sixth Naphtha
Cracking Project
Sheng‐Wei Wang (Taiwan)

P2‐187 (WPAIC) Home Care Nursing Experience of Caring a Chronic Schizophrenia Patient
Chiu‐Jung Chang (Taiwan)

P2‐188 (WPAIC) Family Functioning and Its Related Factors among Taiwanese Individuals with Schizophrenia
Shu‐Yuan Chang (Taiwan)

P2‐189 (AsCNP) Atopic Diathesis Predicts Sequent Hypertension, Dyslipidemia, and Diabetes Mellitus among Patients with
Schizophrenia or Bipolar Disorder: A Nationwide Longitudinal Study
Mu‐Hong Chen (Taiwan)

P2‐190 (AsCNP) GIPR Gene Polymorphism and BMI in Schizophrenia Patients
Shin Ono (Japan)

P2‐191 (AsCNP) Antipsychotic Dose Increase or Stay in Non‐responders with Schizophrenia: A Double‐Blind Randomized
Controlled Trial
Hitoshi Sakurai (Japan)

P2‐192 (AsCNP) Schizophrenia‐Associated Genetic Variants on Chromosome 22q13 Regulate NAGA Gene Expression in
Dorsolateral Prefrontal Cortex
Kazutaka Ohi (Japan)

P2‐193 (AsCNP) Physical Risk Difference among Japanese Outpatients and Inpatients with Schizophrenia:
A Nationwide Survey
Takuro Sugai (Japan)

P2‐194 (AsCNP) Neurogranin‐Deficient Mice Show Behavioral Abnormalities Relevant to Schizophrenia and Neuronal
Immaturity in The Brain
Hideo Hagihara (Japan)

P2‐196 (AsCNP) Improvement of Dumping Syndrome Following a Switch from Olanzapine to Quetiapine in a Patient with
Schizophrenia
Naoki Fukui (Japan)

P2‐197 (AsCNP) Comorbid Obsessive Compulsive Disorder and Social Function in Patients with Chronic Schizophrenia
P2‐198 (AsCNP) Suk‐Hoon Kang (Korea)
P2‐199 (AsCNP)
A Case of Risperidone‐Induced Somnambulism
Ming‐Han Hsieh (Taiwan)

Use of Antidepressants in Patients with Breast Cancer Taking Tamoxifen
Beomwoo Nam (Korea)

- 11 -